Behcet's disease: from east to west

被引:206
|
作者
Davatchi, Fereydoun [1 ]
Shahram, Farhad [1 ]
Chams-Davatchi, Cheyda [1 ]
Shams, Hormoz [1 ]
Nadji, Abdolhadi [1 ]
Akhlaghi, Massoomeh [1 ]
Faezi, Tahereh [1 ]
Ghodsi, Zahra [1 ]
Faridar, Alireza [1 ]
Ashofteh, Farima [1 ]
Abdollahi, Bahar Sadeghi [1 ]
机构
[1] Univ Tehran Med Sci, Shariati Hosp, Rheumatol Res Ctr, Behcets Dis Unit, Tehran 14114, Iran
关键词
Behcet's disease; ASSOCIATION; POPULATION; INVOLVEMENT; GENE;
D O I
10.1007/s10067-010-1430-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Behcet's disease (BD) is classified among vasculitides. There are actually five nationwide surveys of BD: Iran, Japan, China, Korea, and Germany. Among case series, four are on more than 200 cases (Turkey, Morocco, Tunisia, and UK). BD was classically seen around the Silk Route. Now, it is seen everywhere. The male to female ratios were, respectively (in nationwide surveys), 1.19, 0.98, 1.34, 0.63, and 1.40 to 1. The mean age at onset was 26.2, 35.7, 33.8, 29, and 26 years. Major manifestations were seen, respectively, in nationwide surveys: mucous membrane (oral aphthosis in 97%, 98%, 98%, 99%, and 98%; genital aphthosis in 65%, 73%, 76%, 83%, and 64%); skin manifestations (pseudo-folliculitis in 57%, N/A, 31%, N/A, and 62%; erythema nodosum in 22%, N/A, 38%, N/A, and 42%; ocular manifestations in 55%, 69%, 35%, 51%, and 53%). Minor manifestations were seen, respectively, in nationwide surveys: joint manifestations in 33%, 57%, 30%, 38%, and 53%; neurological manifestations in 9%, 11%, 6.5%, 4.6%, and 11%; gastrointestinal manifestations in 7%, 15.5%, 9%, 7.3%, and 12%; vascular involvement in 8.9%, 8.9%, 7.7%, 1.8%, and 13%; pulmonary manifestations in 0.3%, N/A, 2.2%, N/A, and 3.6%; cardiac manifestations in 0.5%, N/A, 4%, N/A, and 3.2%. Laboratory tests are not useful except the pathergy test, which was positive in 54%, 44%, N/A, 40%, and 34% of cases. ESR was normal in many patients. Diagnosis is based upon clinical manifestations. The International Criteria for Behcet's Disease (ICBD, 2006) may be of help, having a sensitivity of 98.2% and a specificity of 95.6% in Iranian patients.
引用
收藏
页码:823 / 833
页数:11
相关论文
共 50 条
  • [11] Behcet's Disease
    Adisen, Esra
    Temel, Berkay
    GAZI MEDICAL JOURNAL, 2019, 30 (02): : 221 - 226
  • [12] Behcet's disease
    Nair, Jagdish R.
    Moots, Robert J.
    CLINICAL MEDICINE, 2017, 17 (01) : 71 - 77
  • [13] Behcet's disease
    Chiheb, S
    Chakib, A
    Lakhdar, H
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2003, 130 (6-7): : 657 - 663
  • [14] Behcet's disease
    Kaklamani, VG
    Vaiopoulos, G
    Kaklamanis, PG
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 1998, 27 (04) : 197 - 217
  • [15] Behcet's Disease
    Behcet, M.
    GEFASSCHIRURGIE, 2012, 17 (08): : 710 - 711
  • [16] Behcet's disease
    Krause, Ilan
    Weinberger, Abraham
    CURRENT OPINION IN RHEUMATOLOGY, 2008, 20 (01) : 82 - 87
  • [17] Behcet's disease
    Hirohata, S
    Kikuchi, H
    ARTHRITIS RESEARCH & THERAPY, 2003, 5 (03) : 139 - 146
  • [18] Behcet's disease
    Castillo Gonzalez, William
    Gonzalez-Argote, Javier
    Hernandez Estevez, Jorge
    REVISTA CUBANA DE REUMATOLOGIA, 2014, 16 (03): : 309 - 321
  • [19] Behcet's disease
    McDonald, Devon R.
    Lee, Christie
    Abuhaleeqa, Khaled
    Fowler, Robert A.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2007, 176 (09) : 1273 - 1274
  • [20] Behcet's disease
    James, D. Geraint
    JOURNAL OF MEDICAL BIOGRAPHY, 2010, 18 (03) : 164 - 164